HIV type 2 protease, reverse transcriptase, and envelope viral variation in the PBMC and genital tract of ARV-naive women in Senegal

AIDS Research and Human Retroviruses

Volumn 24, Issue 6, 2008, Pages 857-864

  Gottlieb, Geoffrey S ^a   Hawes, Stephen E ^b   Wong, Kim G ^a   Raugi, Dana N ^a   Agne, Habibatou D ^c   Critchlow, Cathy W ^b   Kiviat, Nancy B ^a   Sow, Papa Salif ^c  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITÉ CHEIKH ANTA DIOP   (Senegal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; DNA; EMTRICITABINE; LAMIVUDINE; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; ENVELOPE GENE; FEMALE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENITAL SYSTEM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN TISSUE; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PHYLOGENY; PREDICTOR VARIABLE; PRIORITY JOURNAL; SENEGAL; UNINDEXED SEQUENCE; VIRAL GENETICS; VIRUS RESISTANCE;

ADULT; AMINO ACID SEQUENCE; ANTI-HIV AGENTS; CERVIX UTERI; DRUG RESISTANCE, VIRAL; ENV GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; FEMALE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-2; HUMANS; LEUKOCYTES, MONONUCLEAR; LIKELIHOOD FUNCTIONS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; POLYMORPHISM, GENETIC; RNA, VIRAL; SENEGAL; SEQUENCE ANALYSIS, PROTEIN; VAGINA;

EID: 45749108675     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.2008.0015     Document Type: Article

References (15)

1. De Cock KM, Adjorlolo G, Ekpini E, et al.: Epidemiology and transmission of HIV-2. Why there is no HIV-2 pandemic. JAMA 1993;3:270:2083- 2086. [Published erratum appears in JAMA 1994;271(3):196; see comments.]
2. Simon F, Matheron S, Tamalet C, et al.: Cellular and plasma viral load in patients infected with HIV-2. AIDS 1993;7:1411-1417.
3. Marlink R, Kanki P, Thior I, et al.: Reduced rate of disease development after HIV-2 infection as compared to HIV-1. Science 1994;265:1587-1590.
4. Kanki PJ, Travers KU, MBoup S, et al.: Slower heterosexual spread of HIV-2 than HIV-1. Lancet 1994;343:943-946.
5. Gottlieb GS, Sow PS, Hawes SE, et al.: Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis 2002; 185:905-914.
6. Pieniazek D, Rayfield M, Hu DJ, et al.: HIV-2 protease sequences of subtypes A and B harbor multiple mutations associated with protease inhibitor resistance in HIV-1. AIDS 2004;18:495-502.
7. Smith RA, Gottlieb GS, Anderson DJ, Pyrak CL, and Preston BD: Human immunodeficiency virus types 1 and 2 exhibit comparable sensitivity to AZT and other nucleoside analog inhibitors in vitro. Antimicrob Agents Chemother 2007; 52(1):329-332.
8. Ruelle J, Sanou M, Liu HF, Vandenbroucke AT, Duquenne A, and Goubau P: Genetic polymorphisms and resistance mutations of HIV type 2 in antiretroviral-naive patients in Burkina Faso. AIDS Res Hum Retroviruses 2007;23:955-964.
9. Gottlieb GS, Sow PS, Hawes SE, et al.: Molecular epidemiology of dual HIV-1/HIV-2 seropositive adults from Senegal, West Africa. AIDS Res Hum Retroviruses 2003;19:575-584.
10. Rodes B, Holguin A, Soriano V, et al.: Emergence of drug resistance mutations in human immunodeficiency virus type 2-infected subjects undergoing antiretroviral therapy. J Clin Microbiol 2000;38:1370-1374.
11. Gao F, Yue L, Robertson DL, et al.: Genetic diversity of human immunodeficiency virus type 2: Evidence for distinct sequence subtypes with differences in virus biology. J Virol 1994;68:7433-7447.
12. Slatkin M and Maddison WP: A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 1989; 123:603-613.
13. Damond F, Brun-Vezinet F, Matheron S, et al.: Polymorphism of the human immunodeficiency virus type 2 (HIV-2) protease gene and selection of drug resistance mutations in HIV-2-infected patients treated with protease inhibitors. J Clin Microbiol 2005;43:484-487.
14. Sankale JL, Mboup S, Essex ME, and Kanki PJ: Genetic characterization of viral quasispecies in blood and cervical secretions of HIV-1- and HIV-2-infected women. AIDS Res Hum Retroviruses 1998;14:1473-1481.
15. Seck K, Samb N, Tempesta S, et al.: Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal. Sex Transm Infect 2001;77:190-193.